🇺🇸 Dosing Interruption of Natalizumab in United States

Dosing Interruption of Natalizumab (Dosing Interruption of Natalizumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dosing Interruption of Natalizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dosing Interruption of Natalizumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dosing Interruption of Natalizumab in United States?

Berkovich, Regina MD, PhD Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.